Neuronetics Stock

Neuronetics EBIT

The EBIT of Neuronetics (STIM) as of Jun 23, 2026 is -31.44 T USD.In the previous year, EBIT was -30.56 T USD — a change of 2.86% (lower).

EBIT

-31.44 TUSD

YoY

2.86%

Last updated:

In 2026, Neuronetics's EBIT was -31.44 T USD, a 2.86% increase from the -30.56 T USD EBIT recorded in the previous year.

The Neuronetics EBIT history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT (undefined USD)
Date
EBIT (undefined USD)
Jan 1, 2016
0 base
Jan 1, 2017
0 base
Jan 1, 2018
0 base
Jan 1, 2019
0 base
Jan 1, 2020
0 base
Jan 1, 2021
0 base
Jan 1, 2022
0 base
Jan 1, 2023
0 base
Jan 1, 2024
0 base
Jan 1, 2025
0 base
Invalid Date
0 base
Invalid Date
0 base
Invalid Date
0 base
Invalid Date
0 base
YEAREBIT (undefined USD)
2029 est -
2028 est -
2027 est -
2026 est -
2025 -
2024 -
2023 -
2022 -
2021 -
2020 -
2019 -
2018 -
2017 -
2016 -
Access this data via the Eulerpool API

Neuronetics Revenue

Neuronetics Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2016
34.23 M USD
-9.34 M USD
-11.23 M USD
Jan 1, 2017
40.43 M USD
-13.61 M USD
-16.06 M USD
Jan 1, 2018
52.78 M USD
-19.83 M USD
-24.1 M USD
Jan 1, 2019
62.66 M USD
-26.93 M USD
-29.04 M USD
Jan 1, 2020
49.24 M USD
-22.31 M USD
-27.45 M USD
Jan 1, 2021
55.31 M USD
-27.56 M USD
-31.19 M USD
Jan 1, 2022
65.21 M USD
-35.11 M USD
-37.16 M USD
Jan 1, 2023
71.35 M USD
-30.55 M USD
-30.19 M USD
Jan 1, 2024
74.89 M USD
-30.56 M USD
-43.71 M USD
Jan 1, 2025
149.16 M USD
-31.44 M USD
-39 M USD
Invalid Date
165.72 M USD
-25.3 M USD
-30.94 M USD
Invalid Date
185.47 M USD
-20.18 M USD
-21.98 M USD
Invalid Date
217.46 M USD
-17.65 M USD
-1.35 M USD
Invalid Date
242.25 M USD
-16.22 M USD
0 USD

Neuronetics Margins

Neuronetics stock margins

The Neuronetics margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Neuronetics. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Neuronetics.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2016
80.66 %
-27.29 %
-32.81 %
Jan 1, 2017
76.18 %
-33.66 %
-39.72 %
Jan 1, 2018
76.41 %
-37.57 %
-45.66 %
Jan 1, 2019
75.44 %
-42.98 %
-46.35 %
Jan 1, 2020
76.54 %
-45.31 %
-55.75 %
Jan 1, 2021
78.94 %
-49.83 %
-56.39 %
Jan 1, 2022
76.25 %
-53.84 %
-56.99 %
Jan 1, 2023
72.47 %
-42.82 %
-42.31 %
Jan 1, 2024
72.32 %
-40.81 %
-58.36 %
Jan 1, 2025
48.48 %
-21.08 %
-26.15 %
Invalid Date
48.48 %
-15.26 %
-18.67 %
Invalid Date
48.48 %
-10.88 %
-11.85 %
Invalid Date
48.48 %
-8.11 %
-0.62 %
Invalid Date
48.48 %
-6.69 %
0 %

Neuronetics Stock analysis

What does Neuronetics do? Neuronetics Inc is a globally leading company in the field of non-invasive neuromodulatory technology. It was founded in 2003 and is headquartered in Malvern, Pennsylvania. The company specializes in the development and production of transcranial magnetic stimulation devices that can be used in the treatment of psychiatric disorders, particularly severe depression. Neuronetics' business model is based on selling its patented technology, called NeuroStar Advanced Therapy, to medical facilities worldwide. The company works closely with leading psychiatrists and clinical neurophysiologists to ensure that their devices meet the highest quality standards and can provide the best possible help to patients. The company has achieved a number of significant milestones in recent years. For example, in 2008, it received the first FDA approval for its technology. Since then, Neuronetics has continuously developed and improved its technology and has also obtained approvals in Europe and other parts of the world. Neuronetics is divided into various divisions, including research and development, manufacturing, and sales. Each of these departments is focused on ensuring the highest quality standards and ensuring that the technology of NeuroStar Advanced Therapy meets the needs of patients and medical personnel. The technology of NeuroStar Advanced Therapy is based on transcranial magnetic stimulation (TMS), which uses gentle magnetic fields to stimulate the activity of certain brain regions. The stimulation can help restore the balance of neurotransmitters in the brain and thus alleviate depression. Treatment with NeuroStar Advanced Therapy has significant advantages over conventional antidepressant medications. In many cases, it leads to faster improvement of symptoms and does not cause any of the undesirable side effects that can occur with medication. Overall, Neuronetics has developed a revolutionary technology with NeuroStar Advanced Therapy that can help millions of people around the world overcome their depression. The company is proud to contribute to improving the quality of life for people and will continue to develop innovative solutions in the field of neuromodulatory technology in the future. Neuronetics is one of the most popular companies on Eulerpool.

EBIT Details

Analyzing Neuronetics's EBIT

Neuronetics's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.

Year-to-Year Comparison

A yearly comparison of Neuronetics's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.

Impact on Investments

Neuronetics's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.

Interpreting EBIT Fluctuations

Fluctuations in Neuronetics’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.

Frequently Asked Questions about Neuronetics stock

EBIT of Neuronetics amounted to -30.56 T USD -31.44 T

The sales revenue is important for evaluating a stock.

EBIT is an acronym for "Earnings Before Interest and Tax" and represents a company's gross profit before taxes and interest are deducted. The EBIT amount is often used as a metric to evaluate a company.

History

The EBIT was originally introduced in the 1940s when the US Internal Revenue Service (IRS) passed a new tax law. This law required companies to calculate their profit before deducting taxes and interest on loans (or "interest and taxes"). Since then, the EBIT has been used as one of the key financial indicators in evaluating a company.

Usage

The EBIT can be used to assess a company by comparing its financial results to a benchmark or a comparative value. The EBIT is also used to determine how much the company's shareholders will receive from its operating income.

Calculation

EBIT is calculated by deducting taxes and interest on loans from the company's net profit. This amount can be calculated in various ways, but the most common method is as follows:

EBIT = Net profit + interest and taxes

Example: Eulerpool: Your source for quantitative stock data At Eulerpool, we are dedicated to providing you with comprehensive and accurate stock information. Our website offers a wide range of tools and features, including charts, stock lists, and more. Whether you are an experienced investor or just starting out, our platform is designed to meet your needs. With our in-depth analytics and algorithms, you can make informed decisions and stay ahead of the market. Explore our extensive collection of stocks, track their performance, and access real-time data. With Eulerpool, you can easily navigate the world of finance and monitor the stocks that matter to you. Join our community today and gain valuable insights into the world of stocks and investments. Sign up for free and discover the power of Eulerpool. Stay informed. Stay ahead. Eulerpool - your trusted partner in stock data.
Net profit of XYZ Co. = $1,000,000
Interest and taxes = $ 500,000
EBIT of XYZ Co. = $1,500,000

Application

The EBIT value is often used to determine and evaluate the financial stability of a company. The EBIT value can also be used to determine how much money a company can spend on investments or dividends.

Use of EBIT in stock investment

Investors use EBIT to determine if a stock is over- or undervalued. If a company has a high EBIT value, it may indicate that its stock is overvalued, as the profit it generates could be lower than what it would generate with a different stock.

Advantages of EBIT

EBIT is a helpful measure for determining the financial stability of a company. There are several advantages associated with using EBIT, such as:
- EBIT eliminates the impact of financing on the company's earnings.
- It is a useful measure for determining the profits that a company can distribute to its shareholders.
- It can be used to determine whether a stock is overvalued or undervalued.

Disadvantages of EBIT

There are also some disadvantages to using EBIT, such as:
- EBIT cannot be used as the sole measure to evaluate a company as it does not reflect the overall profit of the company.
- EBIT can be influenced by unforeseen events such as a tax increase.
- EBIT is not always a reliable indicator of a company's future profit development.

Conclusion

The EBIT is an important measure used to evaluate a company. It can be used to determine how much money a company can generate from its operational results and whether a stock is overvalued or undervalued. However, the EBIT also has some disadvantages as it does not reflect the overall profitability of a company and can be influenced by unforeseen events. Therefore, it is important to consider the EBIT in conjunction with other financial indicators to obtain a complete picture of the company.

Access this data via the Eulerpool API

Income Statement — Neuronetics

All Key Metrics — Neuronetics